• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk

    Nutritional Growth Solutions’ Healthy Heights Enters South Korea Market
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    ESHA Research

    Ecuadorian Rainforest

    Xsto Solutions

    Botanic Healthcare LLC

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    ESHA Research

    Ecuadorian Rainforest

    Xsto Solutions

    Botanic Healthcare LLC

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients

    According to product recall reports, just a portion of products containing illegal ingredients were recalled following the issuance of warning letters.

    JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients
    Related CONTENT
    • NJ Labs Warns Industry of FDA Warning Letters on Water Testing
    • FDA Issues Final Guidance on NAC Supplements
    • Krill Oil Study Provides Evidence of Osteoarthritis Benefits
    • Folic Acid Appears Beneficial in Type 2 Diabetes
    • Boswellia Serrata Extract Shown in Study to Support Joint Function in Five Days
    By Mike Montemarano, Associate Editor08.02.22
    The U.S. Food and Drug Administration (FDA) sends warning letters to companies marketing supplements or ingredients that the agency deems to be illegal and/or fail to meet the definition of a dietary supplement.

    In order to develop an estimate of how many companies follow through with removing illegal and potentially dangerous substances from the dietary supplements market, a team of researchers led by Pieter Cohen, MD, of Cambridge Health Alliance, writing in JAMA, tracked FDA warning letters for unapproved stimulants present in products on the market.

    They assessed the frequency at which these products were removed following the receipt of an FDA warning letter, specifically with warning letters which addressed amphetamine, ephedrine, and some other drugs, which are known to carry serious health risks including hemorrhagic stroke and sudden death.

    “Whether FDA warning letters lead manufacturers to recall or reformulate products is unknown. We assessed the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters,” the authors wrote.

    FDA issued warning letters for the unapproved stimulants BMPEA, the ephedrine analogue methylsynephrine, and DMHA in 2015, 2016, and 2019, respectively. Using Google, manufacturer’s websites, and the FDA’s websites, the team searched for evidence of recalls of the implicated products.

    Products that remained for sale online were purchased, and powder from these products was reconstituted and analyzed for the presence and quantity of FDA-prohibited ingredients using liquid chromatography-mass spectrometry.

    Of the 31 products targeted in warning letters for the presence of BMPEA, methylsynephrine, or DMHA, only one product was recalled by the manufacturer. Meanwhile, 29% of the products remained online for an average of six years after FDA issued warning letters. Four of the nine products that were still for sale online listed the presence of at least one prohibited ingredient on the label—one product listed the same prohibited ingredient mentioned in a warning letter, while three product labels declared other FDA-prohibited ingredients.

    Five of the nine products still available on the market were found to contain at least one FDA-prohibited ingredient.

    In total, 29% of the products targeted by FDA warning letters remained available for purchase, and most of them were adulterated with unapproved ingredients.

    “This study raises questions regarding the FDA’s actions to ensure that manufacturers are compliant with the agency’s warning letters. The FDA should consider ways to ensure that prohibited drugs are removed from supplements, perhaps by testing products sold after warning letters and mandating recalls whenever products remain adulterated,” the authors concluded.

    Time to Act on Authority 

    Megan Olsen, senior vice president and general counsel at the Council for Responsible Nutrition (CRN), said that warning letters alone aren’t consequential enough to be perceived as sufficient threats to bad actors.

    “It is unfortunately the case that the agency is not doing its job when one can find the same rogue ingredients in the same bad products six years after warning letters have been issued,” Olsen said. “This study demonstrates that warning letters alone are not viewed as sufficient threats by bad actors and outliers. FDA should stop assuming that everyone in the market wants to do the right thing.

    “FDA has recently been asking for new so-called ‘prohibited acts’ authority to clean up the industry,” she added. “In other words, FDA wants clear-cut ability to address illicit substances that have never been marketed as drugs, nor even studied for their potential effects, but are nevertheless marketed as supplements.”

    CRN supports this legislative priority, insofar as expanding the agency’s authority over substances that aren’t implicated by the “drug preclusion” clause of the Dietary Supplements Health and Education Act (DSHEA). While the agency can mandate recalls of dietary supplement products, it is only done in rare instances. The agency often instead requests that companies conduct voluntary recalls.

    “These illicit substances may be currently caught in a legal no-man’s land—not supplements, not drugs, and without this new authority, not clearly within FDA’s enforcement,” Olsen said. “This simple change to the law, currently part of the Senate HELP committee’s user fee legislation, would give FDA capacity that much of the industry believes it already has but FDA has been requesting explicit statutory language to clarify.”

    Like Olsen, Scott Melville, president and CEO of the Consumer Healthcare Products Association (CHPA) said that he also supports comprehensive reforms to offer FDA clear authority to go after products that contain dangerous prohibited ingredients.

    “There can be no tolerance for illegal products masquerading as dietary supplements, especially after a manufacturer has already received an FDA warning letter. Yet, that is precisely what was found […] The troubling situation highlights the need for increased enforcement of current law by the FDA and the Department of Justice, and the need for more comprehensive reform of dietary supplement regulation.”

    According to Melville, the mandatory product listing (MPL) provision of the current user fee registration bill being considered by Congress won’t go far enough. Beyond MPL, he said FDA should also be able to increase facility inspections and remote regulatory assessments, the latter of which is an informal assessment of a facility that was introduced during the height of the COVID-19 pandemic.

    “As the House and Senate confer on FDA user fee reauthorizations, the need to balance consumer access to safe and beneficial dietary supplements with FDA’s ability to swiftly remove dangerous and illegal products from the marketplace should be recognized to ensure that any agree-to reforms are meaningful and not reform in name only,” Melville said.

    NPA: FDA Should Do More with the Tools it Has

    According to Daniel Fabricant, PhD, president and CEO of the Natural Products Association (NPA), FDA appears unwilling to take steps such as product seizures and injunctions, which it already has the authority to do. In contrast to CRN, NPA does not support granting the agency more authority when it doesn’t utilize existing tools. 

    Another point of contention is the fact that FDA’s facility inspections have been declining in frequency some time, irrespective of funding, Fabricant said. He noted that a report from the Office of the Inspector General concluded that even in response to significant inspection violations, follow-up from the agency to ensure corrections were made by the facility was rare.

    “This study reaffirms FDA’s performance failure gaps going back to a report published by the Office of the Inspector General in 2017. Companies who receive a warning letter are required to notify FDA within 15 days of receipt of their warning letter and the specific steps they have taken to address any violations. Failure to do so is supposed to result in legal action including seizure and injunction. This should be considered low-hanging fruit for the agency but it’s obvious there’s an element of willpower that’s absent.

    “These gaps in actions indicate that new authorities to the FDA clearly aren’t warranted, when current authorities, where problems have been located, aren’t followed up with,” Fabricant continued. “This study makes it clear the agency has adequate authority to pursue products masquerading as dietary supplements, the repeated absence of follow-through requires oversight and accountability.”



    Related Searches
    • Dietary Supplements
    • Regulations
    • Testing
    • Quality & Safety
    Related Knowledge Center
    • Testing
    • Quality & Safety
    • Dietary Supplements
    Suggested For You
    NJ Labs Warns Industry of FDA Warning Letters on Water Testing NJ Labs Warns Industry of FDA Warning Letters on Water Testing
    FDA Issues Final Guidance on NAC Supplements FDA Issues Final Guidance on NAC Supplements
    Krill Oil Study Provides Evidence of Osteoarthritis Benefits Krill Oil Study Provides Evidence of Osteoarthritis Benefits
    Folic Acid Appears Beneficial in Type 2 Diabetes Folic Acid Appears Beneficial in Type 2 Diabetes
    Boswellia Serrata Extract Shown in Study to Support Joint Function in Five Days Boswellia Serrata Extract Shown in Study to Support Joint Function in Five Days
    Curcuwin Ultra+ Linked to Positive Findings in Joint Health and Mobility Study Curcuwin Ultra+ Linked to Positive Findings in Joint Health and Mobility Study
    Nutralliance Adds Apple Cider Vinegar to Its Portfolio Nutralliance Adds Apple Cider Vinegar to Its Portfolio
    PepsiCo to Build Largest U.S. Plant Location in Denver PepsiCo to Build Largest U.S. Plant Location in Denver
    The Global Microbiome Market: Top Predictions from ADM The Global Microbiome Market: Top Predictions from ADM
    Open Book Extracts Expands Capabilities to Boost Finished Products Manufacturing Open Book Extracts Expands Capabilities to Boost Finished Products Manufacturing
    Seaweed Extract Could Offer Gastroenteritis Relief Seaweed Extract Could Offer Gastroenteritis Relief
    Saffron Extract May Offer Mental and Physical Benefits in Active Males Saffron Extract May Offer Mental and Physical Benefits in Active Males
    Substantiating Environmental, Social, and Governance Claims Substantiating Environmental, Social, and Governance Claims
    Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms
    Senator Richard Burr Introduces Alternative Legislation Without MPL Provisions Senator Richard Burr Introduces Alternative Legislation Without MPL Provisions

    Related Breaking News

    • Contract Manufacturing | Industry & Market News | Quality & Safety
      NJ Labs Warns Industry of FDA Warning Letters on Water Testing

      NJ Labs Warns Industry of FDA Warning Letters on Water Testing

      Warning letters have been calling out companies that don’t validate their water systems through total organic carbon analysis.
      08.02.22

    • Antioxidants | Breaking News | Dietary Supplements | Regulations | Regulatory News
      FDA Issues Final Guidance on NAC Supplements

      FDA Issues Final Guidance on NAC Supplements

      The agency plans to exercise enforcement discretion on the ingredient after questioning its legality based on drug preclusion.
      08.02.22

    • Bone & Joint Health | Breaking News | Dietary Supplements | Inflammation | Marine Nutraceuticals | Research | Research News
      Krill Oil Study Provides Evidence of Osteoarthritis Benefits

      Krill Oil Study Provides Evidence of Osteoarthritis Benefits

      Adults between the ages of 45 and 60 experienced improved knee pain, stiffness, and physical function.
      07.27.22


    • Breaking News | Diabetes & Blood Sugar Management | Dietary Supplements | Medical Nutrition | Research | Research News | Vitamins
      Folic Acid Appears Beneficial in Type 2 Diabetes

      Folic Acid Appears Beneficial in Type 2 Diabetes

      A clinical study found benefits in blood sugar management in a group of 100 participants.
      07.25.22

    • Bone & Joint Health | Breaking News | Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Research | Research News | Supplier News
      Boswellia Serrata Extract Shown in Study to Support Joint Function in Five Days

      Boswellia Serrata Extract Shown in Study to Support Joint Function in Five Days

      PLT’s AprèsFlex was studied for its short-term effects on joint function in participants with knee osteoarthritis.
      07.25.22

    Loading, Please Wait..
    Trending
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    Breaking News
    • ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    • Tazo Transitions to Regenerative Organic Agriculture
    • Protein Ingredient Formulated for Chronic Kidney Disease Patients
    • IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations
    • Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Protein Ingredient Formulated for Chronic Kidney Disease Patients
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Urges the House to Pass the Inflation Reduction Act
    The ChemQuest Technology Institute Enters Agreement with Universal Matter
    Sherwin-Williams’ TERRA: Embracing Community & Connection in 2023
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Seno Medical's Imagio System Wins Supplemental FDA Approval
    Brad Fluegel Joins NeuroMetrix Board of Directors
    Actuating Implant Design Prevents Scar Tissue Buildup
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Catalent to Acquire Metrics Contract Services for $475M
    Sartorius Stedim Biotech Agrees to Acquire Albumedix
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Anomatic & Novelis Introduce Eco-Friendly Alloy
    NJPEC Announces 2022 Package of the Year Awards
    Tree Hut Introduces New Sugar Scrubs
    Happi

    Latest Breaking News From Happi

    Makeup in New York Returns to the Javits Center on Sept. 14-15
    PASS Coalition Applauds National Academy of Sciences Study on Its Support of Sunscreen as a Skin Cancer Prevention Tool
    Sally Beauty Names Winners of 2022 Cultivate Accelerator Program
    Ink World

    Latest Breaking News From Ink World

    INX to Highlight New Products at Labelexpo Americas
    Sonoco Names Aditya Gandhito Company’s First Chief Accounting Officer
    Quinacridone Pigments Market Size Projected to Reach $539 Million by 2030: Straits
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Heidelberg USA-Gallus opens new Screeny Demo Room in Pennsylvania
    Heidelberg enjoys successful start to financial year
    INX International Ink Co. brings wide product range to Labelexpo Americas
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Vapor Fresh Upgrades Plant-Based Gym Wipe Canisters
    Suominen Releases Half-Year Financial Report
    Essity Switches to Recyclable Packs for Feminine Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cortland Biomedical Adds Suite of Post-Processing Services & Technologies
    First Patient Enrolls in Sonex Health’s U.S. Clinical Study to Treat Carpal Tunnel Syndrome
    Robust Growth Forecast for Joint Reconstruction Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Stratasys Signs Agreement to Acquire Covestro’s Additive Manufacturing Materials Business
    The Future of Electronics RESHAPED Event Reports High Demand
    SEMI Applauds President Biden’s Signing of CHIPS and Science Act of 2022

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login